Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 22337 [2017-09710]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 92 / Monday, May 15, 2017 / Notices
or services to improve population
health.
Strongest consideration will be given
to individuals with expertise and
experience:
• That is applied, with practical
applications for public health action;
• That addresses broad public health
considerations, or is beyond one or two
highly defined areas; and
• In state and/or local health
departments.
In the current round of nominations,
the strongest consideration will also be
given to people with expertise and
experience in systematic review
methods, economic analysis, injury (in
particular substance abuse and violence
prevention), aging, and rural health. The
CPSTF will also benefit from members
with expertise and experience in the
following areas: Minority health;
worksite health; military health and
readiness; and health media,
communications and marketing.
Candidates with experience and skills
in any of these areas should highlight
them in their nomination materials.
All nominated individuals will be
considered for CPSTF membership.
Applicants must have no substantial
conflicts of interest, whether financial,
professional, or intellectual, that would
impair the scientific integrity of the
work of the CPSTF and must be willing
to complete regular conflict of interest
disclosures.
Applicants must have the ability to
work collaboratively with a team of
diverse professionals who support the
mission of the CPSTF. Applicants must
have adequate time to contribute
substantively to the work products of
the CPSTF.
jstallworth on DSK7TPTVN1PROD with NOTICES
Nominee Selection
Appointments to the CPSTF will be
made on the basis of qualifications as
outlined above (see Qualification
Requirements) and the current expertise
needs of the CPSTF.
Time Commitment
The CPSTF conducts three, two-day
meetings each year that are open to the
public. In addition, a significant portion
of the CPSTF’s work occurs between
meetings during conference calls and
via email discussions. Member duties
include overseeing the process of
prioritizing Task Force work,
participating in the development and
refinement of systematic review
methods, serving as members of
individual review teams, and issuing
recommendations and findings to help
inform the decision making process
about policy, practice, research, and
research funding in a wide range of U.S.
VerDate Sep<11>2014
13:51 May 12, 2017
Jkt 241001
settings. The estimated workload for
CPSTF members is approximately 168
hours a year in addition to the three inperson meetings. The members are all
volunteers and do not receive any
compensation beyond support for travel
to in-person meetings.
Dated: May 10, 2017.
Lauren Hoffmann,
Acting Executive Secretary, Centers for
Disease Control and Prevention.
22337
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–09710 Filed 5–12–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–09733 Filed 5–12–17; 8:45 am]
Centers for Disease Control and
Prevention Advisory
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
PAR 13–129, Occupational Safety and
Health Research, NIOSH Member
Conflict Review.
Times and Dates: 1:00 p.m.–4:00 p.m.,
EDT, June 8, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘NIOSH Member Conflict Review’’, PAR
13–129.
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
Officer, NIOSH, CDC, 1095 Willowdale
Road, Mailstop G905, Morgantown,
West Virginia 26506, Telephone: (304)
285–5976.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Committee on Immunization Practices
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
Times and Dates:
8:30 a.m.–5:35 p.m., EDT, June 21, 2017
8:00 a.m.–1:00 p.m., EDT, June 22, 2017
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited
only by the space available. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt is
June 12, 2017. All requests must contain
the name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Please
note that the public comment period
may end before the time indicated,
following the last call for comments.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Written comments
received in advance of the meeting will
be included in the official record of the
meeting.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP Web site: https://
www.cdc.gov/vaccines/acip/.
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 82, Number 92 (Monday, May 15, 2017)]
[Notices]
[Page 22337]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09710]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to PAR 13-129, Occupational Safety and Health
Research, NIOSH Member Conflict Review.
Times and Dates: 1:00 p.m.-4:00 p.m., EDT, June 8, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``NIOSH Member Conflict Review'', PAR 13-129.
Contact Person for More Information: Nina Turner, Ph.D., Scientific
Review Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G905,
Morgantown, West Virginia 26506, Telephone: (304) 285-5976.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-09710 Filed 5-12-17; 8:45 am]
BILLING CODE 4163-18-P
